INCIDENCE AND PREDICTORS OF LONG TERM CARDIOTOXICITY IN ANTRACYCLINE BASED CHEMOTHERAPY IN BREAST CANCER PATIENTS

Rebeca Mata Caballero,J.M. Serrano Antolin,Ia Gonzalez Garcia,J.M. Muniz Garcia,A. Curcio-Ruigomez,C. Gutierrez Landaluce,S. del Castillo Arrojo,C Graupner Abad,C. Cristobal Varela,D. Galan Gil,M.J. Espinosa Pascual,B. Izquierdo Coronel,P. Talavera Calle,V. Gonzalez Pastor,R.M. Jimenez Hernandez,J. Alonso Martin

INCIDENCE AND PREDICTORS OF LONG TERM CARDIOTOXICITY IN ANTRACYCLINE BASED CHEMOTHERAPY IN BREAST CANCER PATIENTS

2019

Rebeca Mata Caballero
J.M. Serrano Antolin
Ia Gonzalez Garcia
J.M. Muniz Garcia
A. Curcio-Ruigomez
C. Gutierrez Landaluce
S. del Castillo Arrojo
C Graupner Abad
C. Cristobal Varela
D. Galan Gil
M.J. Espinosa Pascual
B. Izquierdo Coronel
P. Talavera Calle
V. Gonzalez Pastor
R.M. Jimenez Hernandez
J. Alonso Martin

Anthracycline cardiotoxicity (AC) may manifest years after treatment (long-term AC). The aim of our study was to assess the incidence and predictors of long-term AC in these pts. One hundred consecutive pts receiving Anthracycline-based chemotherapy (CHT) were included in this prospective study. A

Keywords:

Prospective cohort study
Breast cancer
Oncology
Anthracycline
Internal medicine
Diabetes mellitus
Cardiology
Cardiotoxicity
Chemotherapy
Medicine
after treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations